Healthcare provider profile · identity verified

Mahnaz Jalali, MD

Family Practice · SAN DIEGO, CA · NPI 1619025640

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	704	241
Levothyroxine Sodium	Levothyroxine Sodium	357	105
Amlodipine Besylate	Amlodipine Besylate	352	122
Losartan Potassium	Losartan Potassium	305	117
Rosuvastatin Calcium	Rosuvastatin Calcium	274	95
Lisinopril	Lisinopril	270	90
Ozempic	Semaglutide	202	35
Metformin Hcl Er	Metformin Hcl	194	70
Alendronate Sodium	Alendronate Sodium	192	68
Fluoxetine Hcl	Fluoxetine Hcl	165	58
Famotidine	Famotidine	158	83
Metformin Hcl	Metformin Hcl	150	50
Sertraline Hcl	Sertraline Hcl	148	65
Omeprazole	Omeprazole	145	68
Meloxicam	Meloxicam	142	63
Simvastatin	Simvastatin	134	41
Gabapentin	Gabapentin	133	61
Trazodone Hcl	Trazodone Hcl	131	56
Pantoprazole Sodium	Pantoprazole Sodium	126	51
Prednisone	Prednisone	120	74
Atenolol	Atenolol	119	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	118	28
Azelastine Hcl	Azelastine Hcl	117	78
Escitalopram Oxalate	Escitalopram Oxalate	110	47
Tamsulosin Hcl	Tamsulosin Hcl	110	45
Bupropion Xl	Bupropion Hcl	104	39
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	19
Triamcinolone Acetonide	Triamcinolone Acetonide	99	47
Albuterol Sulfate Hfa	Albuterol Sulfate	96	48
Duloxetine Hcl	Duloxetine Hcl	94	37
Hydrochlorothiazide	Hydrochlorothiazide	94	36
Furosemide	Furosemide	92	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	26
Ezetimibe	Ezetimibe	88	29
Estradiol	Estradiol	84	44
Breyna	Budesonide/Formoterol Fumarate	82	55
Metoprolol Tartrate	Metoprolol Tartrate	80	31
Alprazolam	Alprazolam	78	18
Potassium Chloride	Potassium Chloride	72	28
Glipizide	Glipizide	71	28
Hydrocortisone	Hydrocortisone	70	41
Lorazepam	Lorazepam	69	20
Mirtazapine	Mirtazapine	64	30
Lovastatin	Lovastatin	63	23
Terazosin Hcl	Terazosin Hcl	61	20
Citalopram Hbr	Citalopram Hydrobromide	55	22
Bupropion Hcl Sr	Bupropion Hcl	54	25
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	52	50
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	52	21
Spironolactone	Spironolactone	51	20
Cephalexin	Cephalexin	50	38
Allopurinol	Allopurinol	49	20
Lactulose	Lactulose	49	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	48	32
Ibuprofen	Ibuprofen	48	21
Ketoconazole	Ketoconazole	47	20
Acyclovir	Acyclovir	46	24
Metoprolol Succinate	Metoprolol Succinate	46	18
Azithromycin	Azithromycin	45	39
Acetaminophen-Codeine	Acetaminophen With Codeine	43	25
Amoxicillin	Amoxicillin	43	31
Pradaxa	Dabigatran Etexilate Mesylate	43	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	42	42
Pravastatin Sodium	Pravastatin Sodium	42	14
Wixela Inhub	Fluticasone Propion/Salmeterol	42	15
Hydralazine Hcl	Hydralazine Hcl	41	15
Glipizide Er	Glipizide	40	14
Bisoprolol Fumarate	Bisoprolol Fumarate	39	15
Donepezil Hcl	Donepezil Hcl	39	16
Carvedilol	Carvedilol	38	14
Clopidogrel	Clopidogrel Bisulfate	38	15
Topiramate	Topiramate	37	17
Retin-A	Tretinoin	36	18
Cefuroxime	Cefuroxime Axetil	35	28
Propranolol Hcl	Propranolol Hcl	35	12
Ciclopirox	Ciclopirox	34	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	12
Mupirocin	Mupirocin	33	23
Repatha Sureclick	Evolocumab	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	32	32
Chlorthalidone	Chlorthalidone	31	12
Ondansetron Odt	Ondansetron	31	15
Spiriva Respimat	Tiotropium Bromide	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	17
Naproxen	Naproxen	29	12
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	24
Nabumetone	Nabumetone	28	suppressed
Nitroglycerin	Nitroglycerin	28	14
Fluocinonide	Fluocinonide	27	17
Temazepam	Temazepam	27	suppressed
Eliquis	Apixaban	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	11
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	12
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Primidone	Primidone	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Finasteride	Finasteride	22	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	suppressed
Fluconazole	Fluconazole	20	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	18
Nystatin	Nystatin	19	11
Victoza 3-Pak	Liraglutide	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Humulin N	Insulin Nph Human Isophane	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Alvesco	Ciclesonide	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Myrbetriq	Mirabegron	16	11
Trospium Chloride	Trospium Chloride	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Buspirone Hcl	Buspirone Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Metronidazole	Metronidazole	13	11
Naratriptan Hcl	Naratriptan Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Proctozone-Hc	Hydrocortisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error